Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04946084 · ClinicalTrials.gov registry record · NA

Dynamic Change and Immune Response to Nasopharyngeal Carriage and Acute Otitis Media Pathogens

A NA study of Acute Otitis Media, sponsored by Rochester General Hospital.

Active
Registry status
NA
Development phase
320
Enrollment target
1
Study location

NCT04946084 is a NA study of Acute Otitis Media that is active but no longer recruiting, run by Rochester General Hospital. The registered enrollment target is 320 participants, below the 367-participant average among 8 other Acute Otitis Media trials with a reported enrollment target (13% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04946084, a NA study of Acute Otitis Media, is active but no longer recruiting, sponsored by Rochester General Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
320 participants
Enrollment target
1
Study location

Study Summary

The investigators seek to conduct a prospective, longitudinal study to identify the dynamic changes in nasopharyngeal (NP) colonization patterns and acute otitis media (AOM) etiology involving antibiotic-resistant Streptococcus pneumoniae (Spn) and Haemophilus influenzae (Hflu).

Conditions Studied

Interventions

  • OTHER Blood Draw
  • PROCEDURE Tympanocentesis
  • OTHER Nasal Phalangeal Swab and Wash

Study Locations (1)

New York

  • Rochester General Hospital - Rochester

Trial Details

FieldValue
Enrollment Target 320 participants
Start Date 2021-01-01
Est. Completion 2026-12-31
Phase NA

Sponsor

Rochester General Hospital

6 total trials

What the Registry Record Tells You About NCT04946084

The ClinicalTrials.gov registry entry for NCT04946084 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 320 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 367-participant average among 8 other Acute Otitis Media trials with a reported enrollment target (13% lower). The listed sponsor is Rochester General Hospital, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acute Otitis Media appearing as the primary indexed condition, and to 3 interventions - of which Blood Draw is the first listed.

NCT04946084 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04946084 about?

NCT04946084 is a clinical study titled "Dynamic Change and Immune Response to Nasopharyngeal Carriage and Acute Otitis Media Pathogens". The investigators seek to conduct a prospective, longitudinal study to identify the dynamic changes in nasopharyngeal (NP) colonization patterns and acute otitis media (AOM) etiology involving antibiotic-resistant Streptococcus pneumoniae (Spn) and Haemophilus influenzae (Hflu).

What is the current status of trial NCT04946084?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 320 participants. The study started on 2021-01-01. Estimated completion is 2026-12-31.

What conditions does trial NCT04946084 study?

This clinical trial studies the following conditions: Acute Otitis Media.

What interventions are being tested in trial NCT04946084?

The interventions under investigation include: Blood Draw (OTHER), Tympanocentesis (PROCEDURE), Nasal Phalangeal Swab and Wash (OTHER).

Who is sponsoring clinical trial NCT04946084?

This trial is sponsored by Rochester General Hospital, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04946084 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Otitis Media

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.